Fenofibrate mouth dissolving tablet for treating hypolipidemic, is prepared using superdisintigrant crospovidone & croscarmellose sodium
2023-10-16
专利权人JAGTAP V A (JAGT-Individual) ; BARSE R K (BARS-Individual) ; BHIVSHET G U (BHIV-Individual) ; NAIK R D (NAIK-Individual)
申请日期2023-10-16
专利号IN202321069941-A
成果简介NOVELTY - Fenofibrate mouth dissolving tablet is prepared using superdisintigrant crospovidone & croscarmellose sodium. USE - Fenofibrate mouth dissolving tablet used for treating hypolipidemic (claimed). No biological data given. ADVANTAGE - The fenofibrate mouth dissolving tablet is novel complementary and alternative medicine and formulation F9 ensures showing better wetting time of 15.5±1.37 S, drug content of 97.49±0.9 and showing F9 batch were selected as optimized batch based on design space ensures wetting time of (Y1)(15.5±1.37) and Hausner's ratio (D2) of (Y2)(17.5±1 .04).
IPC 分类号A61K-031/215 ; A61K-031/216 ; A61K-047/10 ; A61K-047/24 ; A61K-047/32 ; A61K-009/14 ; A61K-009/16 ; A61K-009/20
国家印度
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/19691
专题中国科学院新疆生态与地理研究所
作者单位
1.JAGTAP V A (JAGT-Individual)
2.BARSE R K (BARS-Individual)
3.BHIVSHET G U (BHIV-Individual)
4.NAIK R D (NAIK-Individual)
推荐引用方式
GB/T 7714
NAIK R D. Fenofibrate mouth dissolving tablet for treating hypolipidemic, is prepared using superdisintigrant crospovidone & croscarmellose sodium. IN202321069941-A[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。